RT @ACCinTouch: (1/11) #ACCGeriatric/#ACCCVT #Tweetorial: Let’s start with a look at the problem of medication overload: 40% of older adult…
@lowninstitute @cardskrish @ParagGoyalMD @beaverspharmd @HFnursemaghee @KAlexanderMD @JDodsonMD @MikeSteinman (11/11) #ACCGeriatric/#ACCCVT #Tweetorial: What are the benefits of reducing adverse drug events? https://t.co/a2QXtPwLYK https://t.co/pHh5iVvXby
@accpcardprn @ACCP @ASHPOfficial @ATRIUMRx
@lowninstitute @cardskrish @ParagGoyalMD @beaverspharmd @HFnursemaghee @KAlexanderMD @JDodsonMD @MikeSteinman (10/11) #ACCGeriatric/#ACCCVT #Tweetorial: More research is needed on the impact, timing and implementation of deprescribing. What studies or prac
@lowninstitute @cardskrish @ParagGoyalMD @beaverspharmd @HFnursemaghee @KAlexanderMD @JDodsonMD @MikeSteinman (9/11) #ACCGeriatric/#ACCCVT #Tweetorial: What challenges do you face around deprescribing cardiovascular medications? https://t.co/a2QXtPwLYK
RT @KAlexanderMD: Although most meds are in evidence free zone, easier to continue than discontinue. https://t.co/nZ4GouGLwC
@SnayCardsPharmD what do you do in practice?
I love to hear people thoughts on this @accpcardprn @ACCP @ASHPOfficial @ATRIUMRx
RT @beaverspharmd: Now this is, again in my opinion, the most critical point of all. It is a team-based approach and we all can practice an…
@GillKentucky
@lowninstitute @cardskrish @ParagGoyalMD @beaverspharmd @HFnursemaghee @KAlexanderMD @JDodsonMD @MikeSteinman (8/11) #ACCGeriatric/#ACCCVT #Tweetorial: Let's 👂your thoughts. When you think about deprescribing medications, how often do you feel you are all
Now this is, again in my opinion, the most critical point of all. It is a team-based approach and we all can practice and support. #ACCCVT @accpcardprn @ASHPOfficial
The team approach is crucial, we have to educate all of our members about the option to deprescribe and the correct strategy to do so #ACCGeriatric #ACCCVT
@lowninstitute @cardskrish @ParagGoyalMD @beaverspharmd @HFnursemaghee @KAlexanderMD @JDodsonMD @MikeSteinman (7/11) #ACCGeriatric/#ACCCVT #Tweetorial: Deprescribing may require multiple healthcare team members: cardiologists, pharmacists, nurses, nurse pr
@accpcardprn anybody have comments
I love this diagram. Amazing work by our #ACCGeriatric group!
@lowninstitute @cardskrish @ParagGoyalMD @beaverspharmd @HFnursemaghee @KAlexanderMD @JDodsonMD @MikeSteinman (6/11) #ACCGeriatric/#ACCCVT #Tweetorial: Here's an overview of DeRx. Take into account all disease agnostic domains when prescribing or deprescri
Anybody else have comments?
RT @ACCinTouch: (1/11) #ACCGeriatric/#ACCCVT #Tweetorial: Let’s start with a look at the problem of medication overload: 40% of older adult…
RT @ACCinTouch: (1/11) #ACCGeriatric/#ACCCVT #Tweetorial: Let’s start with a look at the problem of medication overload: 40% of older adult…
@lowninstitute @cardskrish @ParagGoyalMD @beaverspharmd @HFnursemaghee @KAlexanderMD @JDodsonMD @MikeSteinman (5/11) #ACCGeriatric/#ACCCVT #Tweetorial: Now onto deprescribing trials in older adults with #CVD. https://t.co/a2QXtPwLYK https://t.co/sDruwKfv6M
What other barriers if any do you experience within your organization and patient population? #ACCGeriatric #ACCCVT
@lowninstitute @cardskrish @ParagGoyalMD @beaverspharmd @HFnursemaghee @KAlexanderMD @JDodsonMD @MikeSteinman (4/11) #ACCGeriatric/#ACCCVT #Tweetorial: There are a few barriers to deprescribing. They can stem from one or more of the following. https://t.co
Clearly from the slide, we need more evidence and guidance.
RT @KAlexanderMD: Although most meds are in evidence free zone, easier to continue than discontinue. https://t.co/nZ4GouGLwC
@lowninstitute @cardskrish @ParagGoyalMD @beaverspharmd @HFnursemaghee @KAlexanderMD @JDodsonMD @MikeSteinman (3/11) #ACCGeriatric/#ACCCVT #Tweetorial: Here’s a closer look at the rationale and triggers to deprescribe medications. https://t.co/a2QXtPwLYK h
@accpcardprn @ATRIUMRx
Join us now, Tweetorial in progress!! @ACCinTouch @cardskrish @beaverspharmd @ParagGoyalMD
@lowninstitute @cardskrish @ParagGoyalMD @beaverspharmd @HFnursemaghee @KAlexanderMD @JDodsonMD @MikeSteinman (2/11) #ACCGeriatric/#ACCCVT #Tweetorial: What is DeRx? ➡️Removing medications or decreasing doses ➡️Under healthcare supervision ➡️For a specifi
As I am sure will discuss, often these meds are not optimized or could be potentially used to treat an adverse effect of another (esp maybe none cardiac meds).
RT @ACCinTouch: (1/11) #ACCGeriatric/#ACCCVT #Tweetorial: Let’s start with a look at the problem of medication overload: 40% of older adult…
(1/11) #ACCGeriatric/#ACCCVT #Tweetorial: Let’s start with a look at the problem of medication overload: 40% of older adults take ≥ 5 medications, while ~20% take ≥10 medications. If patient has #heartfailure, the number can ⬆️ to 10-20 medications! https:
Good morning #cardiotwitter excited to see the chatter this morning! Make sure to go follow @ACCinTouch @cardskrish @beaverspharmd @ParagGoyalMD if you haven’t already #ACCGeriatric #ACCCVT
RT @ACCinTouch: Join the ACC for its first #Tweetorial with the #ACCGeriatric and #ACCCVT Sections tomorrow morning! We'll discuss this rec…
RT @ACCinTouch: Join the ACC for its first #Tweetorial with the #ACCGeriatric and #ACCCVT Sections tomorrow morning! We'll discuss this rec…
RT @ACCinTouch: Join the ACC for its first #Tweetorial with the #ACCGeriatric and #ACCCVT Sections tomorrow morning! We'll discuss this rec…
@cardskrish @beaverspharmd @ParagGoyalMD
Join the ACC for its first #Tweetorial with the #ACCGeriatric and #ACCCVT Sections tomorrow morning! We'll discuss this recent JACC Council Perspectives article: https://t.co/a2QXtPwLYK #cvGeri
RT @AllenFrancesMD: #seniors often take 5+ different meds- in too high doses. Some (like benzos, sleeping pills) cause falls/memory loss/…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
RT @Medtorek: Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLoz…
Deprescribing in Older Adults With #Cardiovascular Disease 📌https://t.co/ygLLLyaEXS @vic_pallares @medicosergio @VicenteLozadaB @zbestella @FormigaFrancesc @mendez_bailon @chemachir @SEMERGENap @xgmoll @DrDoblas @Ultracardiodoc @martinfd78 @fcanestro @fc
Great article on #deprescribing in older adults 👵🏽 with cardiovascular disease ❤️, which describes roles of #Pharmacists as members of the cardiovascular clinical team. https://t.co/zIWgLa6Dbo https://t.co/iY5h5ETt99
RT @Deprescribing: Review explores rationale, evidence, and strategies for #deprescribing cardiovascular and some noncardiovascular medicat…
RT @Deprescribing: Review explores rationale, evidence, and strategies for #deprescribing cardiovascular and some noncardiovascular medicat…
Interesting manuscript! @DanijelaGnjidic @luslopes
RT @Deprescribing: Review explores rationale, evidence, and strategies for #deprescribing cardiovascular and some noncardiovascular medicat…
Deprescribing in CAD- Such an important topic and the article is locked behind a paywall! How can we provide better care when we can't access the literature that supports it? @drjohnm @jedicath @HeartOTXHeartMD @ACCinTouch
Review explores rationale, evidence, and strategies for #deprescribing cardiovascular and some noncardiovascular medications. https://t.co/ntf8cvzbpX
RT @krychtiukmd: Deprescribing in Older Adults With Cardiovascular Disease - its hard, it takes time, but it is probably as important as…
RT @rubenoguera: Deprescribing in Older Adults With Cardiovascular Disease - ScienceDirect https://t.co/lpWpOrS7Gq
Deprescribing in Older Adults With Cardiovascular Disease - ScienceDirect https://t.co/lpWpOrS7Gq
Deprescribing in Older Adults With Cardiovascular Disease https://t.co/n26DthgtVb. Wonderful paper! Couldn’t agree more on the usefulness of deprescribing.
"Multimorbid older adults with CVD are disproportionately affected by medication-related issues. #Deprescribing is an integral component of good prescribing practice" @JACCJournals https://t.co/uI9vRz5TCb
RT @UFGIM: Deprescribing in Older Adults With Cardiovascular Disease | JACC: Journal of the American College of Cardiology https://t.co/afJ…
Deprescribing in Older Adults With Cardiovascular Disease | JACC: Journal of the American College of Cardiology https://t.co/afJeXDwa6T
Interessant! https://t.co/OSYgb4fa2T
RT @Sefap_FAP: Deprescribing in Older Adults With Cardiovascular Disease via @BITNavarra https://t.co/8HZh8OsgLS
RT @RafaTorres_IBZ: Acceso a texto completo en PDF en https://t.co/Ib37YYIcnD https://t.co/daz5c9QMaI
RT @BITNavarra: Deprescribing in Older Adults With Cardiovascular Disease https://t.co/FTQ7BWkqkD
RT @Sefap_FAP: Deprescribing in Older Adults With Cardiovascular Disease via @BITNavarra https://t.co/8HZh8OsgLS
RT @RafaTorres_IBZ: Acceso a texto completo en PDF en https://t.co/Ib37YYIcnD https://t.co/daz5c9QMaI
Acceso a texto completo en PDF en https://t.co/Ib37YYIcnD
RT @Sefap_FAP: Deprescribing in Older Adults With Cardiovascular Disease via @BITNavarra https://t.co/8HZh8OsgLS
RT @BITNavarra: Deprescribing in Older Adults With Cardiovascular Disease https://t.co/FTQ7BWkqkD
RT @BITNavarra: Deprescribing in Older Adults With Cardiovascular Disease https://t.co/FTQ7BWkqkD